Agilent Technologies (A) Capital Expenditures Growth (1y) (2010 - 2026)
Powered by 
Analysis
Agilent Technologies (A) Capital Expenditures Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 240.72 Bn | 236.78 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 148.85 Bn | 144.52 Bn | 3.61 Bn | 8.47% |
| 3 | Agilent Technologies | 44.12 Bn | 42.36 Bn | 1.04 Bn | -22.33% |
| 4 | Illumina | 36.18 Bn | 35.01 Bn | 770.00 Mn | 33.33% |
| 5 | Revvity | 16.01 Bn | 14.98 Bn | 416.87 Mn | -41.31% |
| 6 | Bio-Techne | 11.30 Bn | 11.03 Bn | 211.39 Mn | 73.42% |
| 7 | Twist Bioscience | 10.47 Bn | 10.30 Bn | 62.45 Mn | 6.52% |
| 8 | Bio-Rad Laboratories | 10.05 Bn | 8.43 Bn | 345.80 Mn | -29.98% |
| 9 | Repligen | 9.98 Bn | 8.97 Bn | 110.04 Mn | -24.88% |
| 10 | 10x Genomics | 9.98 Bn | 9.43 Bn | 112.50 Mn | 0.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | -22.33% |
| Apr 30, 2026 | -33.33% |
| Jan 31, 2026 | -4.12% |
| Oct 31, 2025 | 0.00% |
| Jul 31, 2025 | 11.96% |
| Apr 30, 2025 | 10.68% |
| Jan 31, 2025 | 7.78% |
| Oct 31, 2024 | 10.71% |
| Jul 31, 2024 | 13.58% |
| Apr 30, 2024 | 80.70% |
| Jan 31, 2024 | 18.42% |
| Oct 31, 2023 | 20.00% |
| Jul 31, 2023 | -1.22% |
| Apr 30, 2023 | -10.94% |
| Jan 31, 2023 | 1.33% |
| Oct 31, 2022 | 12.90% |
| Jul 31, 2022 | 51.85% |
| Apr 30, 2022 | 106.45% |
| Jan 31, 2022 | 82.93% |
| Oct 31, 2021 | 129.63% |